表紙
市場調査レポート

小児心血管インターベンション治療の世界市場 - 先天性心臓欠損(心房中隔欠損孔、心室中隔欠損孔、動脈管開存、左心耳、大動脈弁、肺動脈弁)閉鎖装置および手術市場の予測

Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018

発行 MarketsandMarkets 商品コード 298538
出版日 ページ情報 英文 237 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
小児心血管インターベンション治療の世界市場 - 先天性心臓欠損(心房中隔欠損孔、心室中隔欠損孔、動脈管開存、左心耳、大動脈弁、肺動脈弁)閉鎖装置および手術市場の予測 Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018
出版日: 2014年03月25日 ページ情報: 英文 237 Pages
概要

小児心血管インターベンション治療市場は、症例の増加や装置・治療技術の進歩などの推進要因から、今後数年にわたって健全な成長が見込まれます。

当レポートでは、この小児心血管インターベンション治療の世界市場に注目し、今後2018年までの期間を対象にその推移を治療装置および地域の別に予測するほか、需給の現況や動向を概説しながら、これに携わる産業の発展推進・抑制要因および機会、競合環境、市場シェア、主要企業プロフィールなどの分析・調査情報を集め、概略以下の構成でお届けします。

第1章 イントロダクション

  • 調査の目的
  • レポートの内容説明
  • 調査対象市場
  • レポートの対象利用者層
  • 範囲
  • 調査方法
    • 市場規模の推定
    • 市場区分とデータ三角分析法
    • 市場シェアの算定
    • 一次情報源から得られたデータの需要ポイント
    • 二次情報源から得られたデータの需要ポイント
    • 前提条件

第2章 エグゼクティブサマリー

第3章 特筆すべき考察点

  • 投資動向
  • 技術動向
  • 規制環境
    • 小児心血管治療装置に対する公的認証手続き
    • 知財保護と特許訴訟
  • 医療報酬の状況:経カテーテル心臓弁
  • Porterのファイブフォース分析
  • アンメットニーズ
    • 幼児用に特化した心血管治療装置
  • 成功の必須条件
    • 研究開発投資
    • 事業買収

第4章 市場概要

  • 市場動態
    • 市場推進要因
      • 小児心血管インターベンション装置
        • 行政府支援が小児心血管インターベンション市場の推進力に
        • 認知を高めるプログラムや会議が市場の追い風に
        • 先天性心臓欠陥(CHD)の症例増加で加速する小児心血管インターベンション市場
        • 装置製造メーカーに新たな機会を開く技術の進歩
        • 従来型手術に対する低侵襲療法の優位点が市場成長に寄与
      • 小児心血管映像技術
        • 小児心血管インターベンション映像技術市場を支援するFDA(米国食品医薬品局)の取り組み
    • 市場抑制要因
      • 小児心血管インターベンション装置
        • 複雑な認可申請手続き
        • 厳格さに一貫性を欠く申請手続きで遅れる新製品発売
      • 小児心血映像技術
        • 米国政府による課税
    • 市場機会
      • 小児心血管インターベンション装置
        • 小児心血管治療装置の進歩
        • 大きな成長機会をもたらすアジア太平洋州地域
        • 経カテーテル心臓弁市場の安定成長
      • 小児心血管映像技術
        • モバイルカテーテル検査室 - 次代の有望分野
    • 課題
      • 小児心血管インターベンション装置
        • 小児治験の難しさ
      • 小児心血管映像技術
        • 高額な小児心血管インターベンション映像装置
        • 小規模および新規参入企業の存続
  • 市場シェア分析
    • 構造的心臓欠損閉鎖装置
    • 経カテーテル心臓弁

第5章 小児心血管インターベンション手術

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋州
  • その他の地域

第6章 小児心血管インターベンション装置市場

  • イントロダクション
  • 心臓欠損閉鎖治療装置
    • 心房中隔欠損(ASD)、心室中隔欠損(VSD)、卵円孔開存(PFO)閉鎖治療装置
    • 動脈管開存(PDA)閉鎖治療装置
    • 左心耳(LAA)閉鎖治療装置
  • 経カテーテル心臓弁
    • 経カテーテル肺動脈弁
    • 経カテーテル大動脈弁(TAV)
  • その他
    • 血管形成術用バルーン
    • 血管形成術用ステント
    • カテーテル
    • ガイドワイヤー

第7章 地域分析

  • イントロダクション
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州諸国
  • 北米
    • 米国
    • カナダ
  • アジア太平洋州
  • その他の地域

第8章 競合環境

  • 小児心血管インターベンション映像技術市場
    • イントロダクション
    • 新製品発売
    • 事業買収
    • 協定
    • 事業進出
    • 許認可
  • 小児心血管インターベンション装置市場
    • イントロダクション
    • 事業買収
    • 協定
    • 新製品発売
    • その他の展開
    • 許認可

第9章 企業プロフィール(概要、財務、製品・サービス、戦略、事業展開)

  • 映像技術製品
    • Ge Healthcare (Subsidiary of General Electric Company)
    • Siemens Healthcare (Subsidiary of Siemens AG)
    • 東芝
  • 小児心血管インターベンション装置メーカー
    • Edwards Lifesciences
    • Gore Medical (Subsidiary of W.L. Gore & Associates)
    • Medtronic, Inc.
    • St. Jude Medical
    • Abbott Vascular (A Subsidiary of Abbott Laboratories)
    • Boston Scientific Corporation
    • Cordis Corporation (Subsidiary of Johnson & Johnson)
    • Numed, Inc.

* 非上場企業についてはカッコ内項目の詳細を網羅していないことがあります

図表一覧

目次
Product Code: MD 2296

The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.

In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births. The APAC region is witnessing a number of collaborations between local players and foreign companies for the development of new products. Also, the APAC region is hosting a number of conferences and workshops for discussing new and advanced techniques that are present in the market. These conferences and workshops will help in stimulating innovation in the field of pediatric interventional cardiology, thus aiding the market to grow further.

The global pediatric interventional cardiology market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures are the factors that are likely to hinder the growth of this market. At present, difficulties encountered in clinical trials of pediatric medical devices such as patient recruitment and high cost are the major challenges faced by market players.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauze the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the top players in the pediatric interventional cardiology market. The report also provides the number of cath labs and the number of pediatric cardiology procedures performed across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pediatric interventional cardiology market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the promising applications of pediatric interventional cardiology devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pediatric interventional cardiology market
  • Competitive Assessment: In depth assessment of market shares, strategies, products and services, distribution networks, manufacturing capabilities of leading players, and porters five forces analysis in the pediatric interventional cardiology market

Table of Contents

1 Introduction

  • 1.1 Objectives of the Study
  • 1.2 Report Description
  • 1.3 Markets Covered
  • 1.4 Stakeholders
  • 1.5 Scope
  • 1.6 Research Methodology
    • 1.6.1 Market Size Estimation
    • 1.6.2 Market Crackdown & Data Triangulation
    • 1.6.3 Market Share Calculation
    • 1.6.4 Key Data Points from Primary Sources
    • 1.6.5 Key Data Points from Secondary Sources
    • 1.6.6 Assumptions

2 Executive Summary

3 Premium Insights

  • 3.1 Investment Trends
  • 3.2 Technology Trends
  • 3.3 Regulatory Environment
    • 3.3.1 Regulatory Approval Procedures for Pediatric Cardiology Devices
      • 3.3.1.1 510(K) Application
      • 3.3.1.2 Premarket Approval (Pma) Application
      • 3.3.1.3 Humanitarian Device Exemption (Hde) Application
    • 3.3.2 Intellectual Property Protection and Patent Litigation
  • 3.4 Reimbursement Scenario: Transcatheter Heart Valves
  • 3.5 Porter's Five Forces Analysis: Pediatric Interventional Cardiology Imaging Market
    • 3.5.1 Threat of New Entrants
    • 3.5.2 Bargaining Power of Suppliers
    • 3.5.3 Bargaining Power of Buyers
    • 3.5.4 Competitor Rivalry
    • 3.5.5 Threat of Substitutes
  • 3.6 Unmet Need
    • 3.6.1 Pediatric-Specific Cardiac Devices
  • 3.7 Winning Imperatives
    • 3.7.1 Investments in R&D Activities
    • 3.7.2 Acquisitions

4 Market Overview

  • 4.1 Market Dynamics
    • 4.1.1 Market Drivers
      • 4.1.1.1 Pediatric Interventional Cardiology Devices
        • 4.1.1.1.1 Government Support, An Impetus for the Pediatric Interventional Cardiology Market
        • 4.1.1.1.2 Awareness Programs and Conferences to Fuel the Market
        • 4.1.1.1.3 Rising Incidences of Congenital Heart Defects(CHD)to Propel the Pediatric Interventional Cardiology Market
        • 4.1.1.1.4 Technological Advancements to Open New Opportunities for Device Manufacturers
        • 4.1.1.1.5 Advantages of Minimally Invasive Procedures Over Conventional Surgeries to Propel the Market Growth
      • 4.1.1.2 Pediatric Cardiology Imaging
        • 4.1.1.2.1 Fda's Efforts to Bolster the Pediatric Cardiology Imaging Market
    • 4.1.2 Market Restraints
      • 4.1.2.1 Pediatric Interventional Cardiology Devices
        • 4.1.2.1.1 Complex Regulatory Procedures
        • 4.1.2.1.2 Varied Stringency of Regulatory Procedures Delays Product Launches
      • 4.1.2.2 Pediatric Cardiology Imaging
        • 4.1.2.2.1 Implementation of Excise Tax By the U.S. Government
    • 4.1.3 Market Opportunities
      • 4.1.3.1 Pediatric Interventional Cardiology Devices
        • 4.1.3.1.1 Advances In Biodegradable Devices for Pediatric Cardiology
        • 4.1.3.1.2 Asia-Pacific Region Presents Significant Growth Opportunities
        • 4.1.3.1.3 Robust Growth in the Transcatheter Heart Valves Market
      • 4.1.3.2 Pediatric Cardiology Imaging
        • 4.1.3.2.1 Mobile Cath Labs, An Upcoming Opportunity Area
    • 4.1.4 Challenges
      • 4.1.4.1 Pediatric Interventional Cardiology Devices
        • 4.1.4.1.1 Difficulties in Pediatric Clinical Trials
      • 4.1.4.2 Pediatric Cardiology Imaging
        • 4.1.4.2.1 High Cost of Pediatric Interventional Cardiology Imaging Devices
        • 4.1.4.2.2 Survival of Small Players and New Entrants
  • 4.2 Market Share Analysis
    • 4.2.1 Structural Heart Defect Closure Devices
    • 4.2.2 Transcatheter Heart Valves

5 Pediatric Interventional Cardiology Procedures

  • 5.1 Introduction
  • 5.2 North America
  • 5.3 Europe
  • 5.4 APAC
  • 5.5 ROW

6 Pediatric Interventional Cardiology Devices Market

  • 6.1 Introduction
  • 6.2 Heart Defect Closure Devices
    • 6.2.1 ASD, VSD, & PFO Closure Devices
      • 6.2.1.1 Atrial Septal Defect (ASD) Closure Devices
      • 6.2.1.2 Ventricular Septal Defect (VSD) Closure Devices
      • 6.2.1.3 Patent Foramen Ovale (PFO) Closure Devices
    • 6.2.2 Patent Ductus Arteriosus (Pda) Closure Devices
    • 6.2.3 Left Atrial Appendage (Laa) Closure Devices
  • 6.3 Transcatheter Heart Valves
    • 6.3.1 Transcatheter Pulmonary Valves
    • 6.3.2 Transcatheter Aortic Valves (TAV)
  • 6.4 Others
    • 6.4.1 Angioplasty Balloons
    • 6.4.2 Angioplasty Stents
    • 6.4.3 Catheters
    • 6.4.4 Guidewires

7 Geographic Analysis

  • 7.1 Introduction
  • 7.2 Europe
    • 7.2.1 Germany
    • 7.2.2 France
    • 7.2.3 U.K.
    • 7.2.4 Italy
    • 7.2.5 Spain
    • 7.2.6 Roe
  • 7.3 North America
    • 7.3.1 U.S.
    • 7.3.2 Canada
  • 7.4 Asia-Pacific (APAC)
  • 7.5 Rest of the World (ROW)

8 Competitive Landscape

  • 8.1 Pediatric Interventional Cardiology Imaging Market
    • 8.1.1 Introduction
    • 8.1.2 New Product Launches
    • 8.1.3 Acquisitions
    • 8.1.4 Agreements
    • 8.1.5 Expansions
    • 8.1.6 Approvals
  • 8.2 Pediatric Interventional Cardiology Devices Market
    • 8.2.1 Introduction
    • 8.2.2 Acquisitions
    • 8.2.3 Agreements
    • 8.2.4 New Product Launches
    • 8.2.5 Other Developments
    • 8.2.6 Approvals

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 9.1 Imaging Products Companies
    • 9.1.1 Ge Healthcare (Subsidiary of General Electric Company)
    • 9.1.2 Siemens Healthcare (Subsidiary of Siemens AG)
    • 9.1.3 toshiba Corporation
  • 9.2 Pediatric Interventional Cardiology Device Companies
    • 9.2.1 Edwards Lifesciences
    • 9.2.2 Gore Medical (Subsidiary of W.L. Gore & Associates)
    • 9.2.3 Medtronic, Inc.
    • 9.2.4 St. Jude Medical
    • 9.2.5 Abbott Vascular (A Subsidiary of Abbott Laboratories)
    • 9.2.6 Boston Scientific Corporation
    • 9.2.7 Cordis Corporation (Subsidiary of Johnson & Johnson)
    • 9.2.8 Numed, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

  • Table 1 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
  • Table 2 Number of Pediatric Interventional Cardiology Procedures, By Geography, 2012-2018
  • Table 3 Global Market, By Device Type, 2011-2018 ($Million)
  • Table 4 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
  • Table 5 North America: Pediatric Interventional Cardiology Devices Market, By Country, 2011-2018 ($Million)
  • Table 6 Europe: Pediatric Interventional Cardiology Devices Market, By Country, 2011-2018 ($Million)
  • Table 7 Heart Defect Closure Devices Market, By Device Type, 2011-2018 ($Million)
  • Table 8 Heart Defect Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 9 North America: Heart Defect Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 10 Europe: Heart Defect Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 11 Pediatric ASD, VSD, & PFO Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 12 North America: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 13 Europe: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 14 Major Atrial Septal Devices
  • Table 15 Major Ventricular Septal Defect Closure Devices
  • Table 16 Major Patent Foramen Ovale Closure Devices
  • Table 17 Major Patent Ductus Arteriosus Closure Devices
  • Table 18 Pediatric Pda Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 19 North America: Pediatric Pda Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 20 Europe: Pediatric Pda Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 21 Major Left Atrial Appendage Closure Devices
  • Table 22 Pediatric Laa Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 23 North America: Pediatric Laa Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 24 Europe: Pediatric Laa Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 25 Transcatheter Heart Valves Market, By Device Type, 2011-2018 ($Million)
  • Table 26 Transcatheter Heart Valves Market, By Geography, 2011-2018 ($Million)
  • Table 27 North America: Transcatheter Heart Valves Market, By Country, 2011-2018 ($Million)
  • Table 28 Europe: Transcatheter Heart Valves Market, By Country, 2011-2018 ($Million)
  • Table 29 Major Transcatheter Pulmonary Valve
  • Table 30 Pediatric Transcatheter Pulmonary Valve Device Market, By Geography, 2011-2018 ($Million)
  • Table 31 North America: Transcatheter Pulmonary Valves Market, By Country, 2011-2018 ($Million)
  • Table 32 Europe: Transcatheter Pulmonary Valves Market, By Country, 2011-2018 ($Million)
  • Table 33 Major Transcatheter Aortic Valves
  • Table 34 Pediatric Transcatheter Aortic Valve Device Market, By Geography, 2011-2018 ($Million)
  • Table 35 North America: Transcatheter Aortic Valves Market, By Country, 2011-2018 ($Million)
  • Table 36 Europe: Transcatheter Aortic Valves Market, By Country, 2011-2018 ($Million)
  • Table 37 Other Devices Market, By Geography, 2011-2018 ($Million)
  • Table 38 North America: Other Devices Market, By Country, 2011-2018 ($Million)
  • Table 39 Europe: Other Devices Market, By Country, 2011-2018 ($Million)
  • Table 40 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
  • Table 41 Europe: Market, By Device Type, 2011-2018 ($Million)
  • Table 42 Germany: Market, By Device Type, 2011-2018 ($Million)
  • Table 43 France: Market, By Device Type, 2011-2018 ($Million)
  • Table 44 U.K.: Market, By Device Type, 2011-2018 ($Million)
  • Table 45 Italy: Market, By Device Type, 2011-2018 ($Million)
  • Table 46 Spain: Market, By Device Type, 2011-2018 ($Million)
  • Table 47 Rest of Europe: Market, By Device Type, 2011-2018 ($Million)
  • Table 48 North America: Market, By Device Type, 2011-2018 ($Million)
  • Table 49 U.S.: Market, By Device Type, 2011-2018 ($Million)
  • Table 50 Canada: Market, By Device Type, 2011-2018 ($Million)
  • Table 51 Asia-Pacific (APAC): Market, By Device Type, 2011-2018 ($Million)
  • Table 52 ROW: Market, By Device Type, 2011-2018 ($Million)
  • Table 53 New Product Launch, 2011-2013
  • Table 54 Acquisitions, 2011-2013
  • Table 55 Agreements, 2011-2013
  • Table 56 Expansions, 2011-2013
  • Table 57 Approvals, 2011-2013
  • Table 58 Acqusitions, 2011-2013
  • Table 59 Agreements, 2011-2013
  • Table 60 New Product Launch, 2011-2013
  • Table 61 Other Developments, 2011-2013
  • Table 62 Approvals, 2011-2014
  • Table 63 General Electric: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 64 General Electric: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 65 General Electric: Total Revenue, By Geography, 2011-2013 ($Billion)
  • Table 66 Siemens Healthcare: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 67 Siemens Healthcare: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 68 Siemens Healthcare: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 69 Toshiba Corporation: Total Revenue and R&D Expenditure, 2011-2013 ($Billion)
  • Table 70 Toshiba Corporation: Total Revenue, By Segment, 2011-2013 ($Billion)
  • Table 71 Toshiba Corporation: Total Revenue, By Geography, 2011-2013 ($Billion)
  • Table 72 Edwards Lifesciences: Total Revenue and R&D Expenditure, 2010-2012 ($Million)
  • Table 73 Edwards Lifesciences: Total Revenue, By Segment, 2010-2012 ($Million)
  • Table 74 Edwards Lifesciences: Total Revenue, By Geography, 2010-2012 ($Million)
  • Table 75 Medtronic, Inc.: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 76 Medtronic, Inc.: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 77 Medtronic, Inc.: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 78 St. Jude Medical: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 79 St. Jude Medical: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 80 St. Jude Medical: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 81 Abbott Laboratories: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 82 Abbott Laboratories: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 83 Abbott Laboratories: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 84 Boston Scientific Corporation: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 85 Boston Scientific Corporation: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 86 Boston Scientific Corporation: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 87 Johnson & Johnson: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 88 Johnson & Johnson: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 89 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Segment, 2011-2013 ($Million)
  • Table 90 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Geography, 2011-2013 ($Million)

List of Figures

  • Figure 1 Forecast Model
  • Figure 2 Market Size Estimation Methodology
  • Figure 3 Data Triangulation
  • Figure 4 Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 5 Major Patent Infringement Cases
  • Figure 6 Porter's Five Forces Analysis
  • Figure 7 Market Dynamics
  • Figure 8 Structural Heart Defect Closure Devices Market Share Analysis, By Key Players, 2012
  • Figure 9 Transcatheter Heart Valve Market Share Analysis, By Key Player, 2012
  • Figure 10 Number of Pediatric Interventional Cardiology Procedures & Prevalence of CHD, By Geography, 2012-2018
  • Figure 11 North America: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 12 Europe: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 13 APAC: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 14 ROW: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 15 Pediatric Interventional Cardiology Devices Market, By Device Type
  • Figure 16 Other Devices
  • Figure 17 Pediatric Interventional Cardiology Devices Market, By Geography, 2013 ($Million)
  • Figure 18 Key Growth Strategies, Pediatric Interventional Cardiology Imaging Market, 2011-2014
  • Figure 19 Key Growth Strategies, Pediatric Interventional Cardiology Devices Market, 2011-2014
Back to Top